Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statements of Cash Flows

v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES    
Net income $ (15,062,061) $ (24,179,786)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 84,581 123,532
Noncash change in right-of-use assets 403,828 451,795
Noncash interest expense, net of interest paid 0 (168,556)
Gain on extinguishment of debt 0 (8,624,778)
(Gain) loss on sale of FC2 business (351,418) 4,253,405
Gain on sale of ENTADFI® assets 0 (2,154,134)
Share-based compensation 1,738,286 6,567,376
Deferred income taxes 0 (1,915)
Change in fair value of derivative liabilities 0 3,138,316
Change in fair value of equity securities (4,357,467) 349,078
Other 0 (14,019)
Changes in current assets and liabilities:    
Increase in accounts receivable 0 (657,253)
Decrease in inventories 0 863,928
Decrease (increase) in prepaid expenses and other assets 28,750 (248,677)
Decrease in accounts payable (2,276,120) (1,899,508)
Decrease in accrued expenses and other liabilities (325,962) (1,862,377)
Decrease in operating lease liabilities (434,072) (488,179)
Net cash used in operating activities (20,551,655) (24,551,752)
INVESTING ACTIVITIES    
Proceeds from sale of FC2 business, net of costs 351,418 16,320,964
Cash proceeds from sale of ENTADFI® assets 0 2,154,134
Proceeds from sale of equity securities 4,971,386 393,217
Capital expenditures 0 (1,083)
Net cash provided by investing activities 5,322,804 18,867,232
FINANCING ACTIVITIES    
Payment on extinguishment of residual royalty agreement liabilities 0 (4,221,611)
Payment of deferred equity financing issuance costs (52,914) 0
Proceeds from exercise of pre-funded warrants 1,000 0
Net cash provided by (used in) financing activities 23,314,431 (4,221,611)
Net increase (decrease) in cash, cash equivalents, and restricted cash 8,085,580 (9,906,131)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD 15,794,562 24,916,285
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD 23,880,142 15,010,154
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 332,826
Schedule of noncash investing and financing activities:    
Deferred equity financing issuance costs in accounts payable and accrued expenses and other current liabilities 184,535 0
Public Offering [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of securities in public offering, net of commissions and costs $ 23,366,345 $ 0